All In Biotech

Free tool

FAERS Monitor: Ocrevus

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761053 or its brand name (Ocrevus, Ocrelizumab). Reports on generic versions are filed under their own applications.

Reports

62,729

Serious

31,724

51% of reports

Hospitalization

11,416

Death reported

1,540

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • covid-1911,587
  • fatigue6,297
  • urinary tract infection3,818
  • headache3,311
  • multiple sclerosis3,123
  • multiple sclerosis relapse2,818
  • gait disturbance2,756
  • asthenia2,735
  • nasopharyngitis2,601
  • pain2,585
  • fall2,559
  • drug ineffective2,491
  • off label use2,488
  • pneumonia2,472
  • infusion related reaction2,247

Reports by year received

View as table
YearReports
20071
20081
20091
201010
201113
201217
20137
201412
201510
201630
20171,129
20184,995
20196,275
20205,549
20217,193
202211,405
20238,927
20249,566
20254,551
20263,037

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,430 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
covid-19Signal11,58723.623.2236,586
multiple sclerosisSignal3,12323.422.562,596
multiple sclerosis relapseSignal2,81814.313.833,615
infusion related reactionSignal2,24711.711.321,364
urinary tract infectionSignal3,8187.77.421,761
gait disturbanceSignal2,7564.94.78,463
nasopharyngitisSignal2,6014.84.67,740
fatigueSignal6,2972.72.77,086
fallSignal2,5592.62.52,517
pneumoniaSignal2,4722.62.52,392
astheniaSignal2,7352.42.42,370
headache3,3111.81.71,147
pain2,5851.41.4319
off label use2,4881.00.96
drug ineffective2,4910.60.6564

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.